Compile Data Set for Download or QSAR
Report error Found 14 Enz. Inhib. hit(s) with all data for entry = 50018091
TargetProstacyclin receptor(Human)
Fujisawa Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM50191135(sodium 2-(3-(((1S,2R)-2-(4,5-diphenyloxazol-2-yl)c...)
Affinity DataIC50: 39nMAssay Description:Agonist activity at human PGI2 receptor assessed as inhibition of ADP-induced platelet aggregationMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetProstacyclin receptor(Human)
Fujisawa Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM50191133(sodium (R)-2-(3-((2-(4,5-diphenyloxazol-2-yl)pyrro...)
Affinity DataIC50: 48nMAssay Description:Agonist activity at human PGI2 receptor assessed as inhibition of ADP-induced platelet aggregationMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetProstacyclin receptor(Human)
Fujisawa Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM50191134(sodium 2-(3-(((1S,2S)-2-(4,5-diphenyloxazol-2-yl)c...)
Affinity DataIC50: 53nMAssay Description:Agonist activity at human PGI2 receptor assessed as inhibition of ADP-induced platelet aggregationMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetProstacyclin receptor(Human)
Fujisawa Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM50191132(sodium (S)-2-(3-((2-(4,5-diphenyloxazol-2-yl)pyrro...)
Affinity DataIC50: 58nMAssay Description:Agonist activity at human PGI2 receptor assessed as inhibition of ADP-induced platelet aggregationMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetProstacyclin receptor(Human)
Fujisawa Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM50136234(Sodium; {3-[(R)-2-(4,5-diphenyl-oxazol-2-yl)-cyclo...)
Affinity DataIC50: 60nMAssay Description:Agonist activity at human PGI2 receptor assessed as inhibition of ADP-induced platelet aggregationMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetProstacyclin receptor(Human)
Fujisawa Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM50191137(sodium 2-(3-(((1S,2R)-2-(4,5-diphenyloxazol-2-yl)c...)
Affinity DataIC50: 114nMAssay Description:Agonist activity at human PGI2 receptor assessed as inhibition of ADP-induced platelet aggregationMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetProstacyclin receptor(Human)
Fujisawa Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM50191138(sodium 2-(3-(((1S,2S)-2-(4,5-diphenyloxazol-2-yl)c...)
Affinity DataIC50: 115nMAssay Description:Agonist activity at human PGI2 receptor assessed as inhibition of ADP-induced platelet aggregationMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetProstacyclin receptor(Human)
Fujisawa Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM50136237(sodium 2-(3-((2-(4,5-diphenyloxazol-2-yl)cyclohex-...)
Affinity DataIC50: 533nMAssay Description:Agonist activity at human PGI2 receptor assessed as inhibition of ADP-induced platelet aggregationMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetProstacyclin receptor(Rat)
Fujisawa Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM50191133(sodium (R)-2-(3-((2-(4,5-diphenyloxazol-2-yl)pyrro...)
Affinity DataIC50: 700nMAssay Description:Agonist activity at rat PGI2 receptor assessed as inhibition of ADP-induced platelet aggregationMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetProstacyclin receptor(Human)
Fujisawa Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM50191136(sodium 2-(3-(2-(4,5-diphenyloxazol-2-yl)benzyl)phe...)
Affinity DataIC50: 930nMAssay Description:Agonist activity at human PGI2 receptor assessed as inhibition of ADP-induced platelet aggregationMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetProstacyclin receptor(Rat)
Fujisawa Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM50136234(Sodium; {3-[(R)-2-(4,5-diphenyl-oxazol-2-yl)-cyclo...)
Affinity DataIC50: 1.20E+3nMAssay Description:Agonist activity at rat PGI2 receptor assessed as inhibition of ADP-induced platelet aggregationMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetProstacyclin receptor(Rat)
Fujisawa Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM50191132(sodium (S)-2-(3-((2-(4,5-diphenyloxazol-2-yl)pyrro...)
Affinity DataIC50: 1.00E+4nMAssay Description:Agonist activity at rat PGI2 receptor assessed as inhibition of ADP-induced platelet aggregationMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetProstacyclin receptor(Human)
Fujisawa Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM50136234(Sodium; {3-[(R)-2-(4,5-diphenyl-oxazol-2-yl)-cyclo...)
Affinity DataKi:  60nMAssay Description:Displacement of [3H]iloprost from cloned human PGI2 receptorMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetProstacyclin receptor(Human)
Fujisawa Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM50191133(sodium (R)-2-(3-((2-(4,5-diphenyloxazol-2-yl)pyrro...)
Affinity DataKi:  76nMAssay Description:Displacement of [3H]iloprost from cloned human PGI2 receptorMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed